The Lancet Series on cardiometabolic multiple long-term conditions

https://www.thelancet.com/series-do/cardiometabolic-mltc?dgcid=raven_jbs_etoc_feature_lancetcardiomltc26 Cardiometabolic multiple long-term conditions (multimorbidity), the co-occurrence of interconnected conditions such as type 2 diabetes, cardiovascular disease, and kidney disease, represent a growing global health challenge. Clustering of these conditions is associated with polypharmacy, high rates of morbidity, disproportionate health care utilisation, and premature mortality. Despite rising prevalence in both low- and high-income countries, clinical care and research often remain siloed within single-disease frameworks, resulting in fragmented management and suboptimal outcomes.